Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?

Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?

A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...

書誌詳細
主要な著者:	Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F
フォーマット:	Journal article
言語:	English
出版事項:	Frontiers Media 2021

類似資料

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
著者:: Helen L. Stark, 等
出版事項: (2021-03-01)

An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
著者:: Alzhrani, AI
出版事項: (2021)

Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
著者:: Honeyman, C, 等
出版事項: (2021)

Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
著者:: Honeyman, C, 等
出版事項: (2020)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
著者:: Maja-Theresa Dieterlen, 等
出版事項: (2021-08-01)

Feasibility, long‐term safety and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
著者:: Harden, PN, 等
出版事項: (2020)

Regulatory immune cells in transplantation.
著者:: Wood, K, 等
出版事項: (2012)

When to refer adult patients with congenital heart disease for transplantation: Which criteria to use, which work-up?
著者:: Alexander Van De Bruaene, 等
出版事項: (2021-08-01)

The where and when of T cell regulation in transplantation.
著者:: Issa, F, 等
出版事項: (2013)

The where and when of T cell regulation in transplantation
著者:: Issa, F, 等
出版事項: (2013)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
著者:: Alzhrani, A, 等
出版事項: (2020)

Regulatory B cells in transplantation: roadmaps to clinic
著者:: Beckett, J, 等
出版事項: (2020)

Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy
著者:: Felix J. Hartmann, 等
出版事項: (2019-07-01)

DIGITAL PMMA, WHEN AND WHICH
著者:: Andreea Mariana Bănățeanu, 等
出版事項: (2024-12-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
著者:: Hyeyoung Lee, 等
出版事項: (2017-01-01)

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
著者:: Dominika Deborska-Materkowska, 等
出版事項: (2018-04-01)

Deciphering the contribution of γδ T cells to outcomes in transplantation
著者:: McCallion, O, 等
出版事項: (2018)

The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?
著者:: Jacobson PK, 等
出版事項: (2023-07-01)

A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection
著者:: Kaminski, Michael M., 等
出版事項: (2020)

Evaluation of Minitubers Yield and Scaling which Produced from Microtubers Transplanting Using Soilless Culture Technique
著者:: Falah Hassan Issa
出版事項: (2017-06-01)

Cerebrovascular neuroimaging: Which tests and when?
著者:: Michael Hoffmann
出版事項: (1996-09-01)

Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
著者:: Wright, S, 等
出版事項: (2021)

Opportunities for high-plex spatial transcriptomics in solid organ transplantation
著者:: Cross, AR, 等
出版事項: (2023)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
著者:: Nicola Personeni, 等
出版事項: (2020-03-01)

Towards regulatory cellular therapies in solid organ transplantation
著者:: Bottomley, MJ, 等
出版事項: (2021)

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation
著者:: Brook, MO, 等
出版事項: (2024)

Infections in transplant “Bugs which bug transplantation in India”
著者:: Manisha Sahay
出版事項: (2017-01-01)

What moves where when in which languages?
著者:: Richards, Norvin W. (Norvin Waldemar), 1971-
出版事項: (2008)

Investigations in West Syndrome: Which, When and Why
著者:: Richard E Appleton
出版事項: (2015-06-01)

Characterising the immune response to combined skin and solid organ transplants
著者:: Stark, H
出版事項: (2022)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
著者:: Antje R. Weseler, 等
出版事項: (2023-05-01)

IL‐33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
著者:: Kawai, K, 等
出版事項: (2020)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
著者:: Carroll, R, 等
出版事項: (2013)

Imaging the cellular components of the immune system for advancing diagnosis and immunotherapy of cancers
著者:: K. Bhise, 等
出版事項: (2021-06-01)

Extracorporial Knots in Laparoscopic Surgery: Which, When, and How
著者:: Omar Salem Khattab
出版事項: (2008-10-01)

Alternatives to norepinephrine in septic shock: Which agents and when?
著者:: Mathieu Jozwiak
出版事項: (2022-10-01)

Which Test to Perform for Cystic hydatic Diagnosis and When?
著者:: Zahra Arab-Mazar, 等
出版事項: (2020-06-01)

When will European Muslim population be majority and in which country?
著者:: Pierre Rostan, 等
出版事項: (2020-09-01)

Stent for Crohn’s disease strictures: Which one and when?
著者:: Alain Attar
出版事項: (2016-03-01)

Blood component therapy: Which, when and how much
著者:: Rajesh Chand Arya, 等
出版事項: (2011-01-01)